Nils Briel
@nbriel.bsky.social
Neurology Resident @unispitalzuerich.bsky.social | PostDoc Fellow in Arosio Group @ethz.ch | Interested in biomarkers and molecular pathology of #Tauopathies, #HD and #ALS
Reposted by Nils Briel
We're thrilled to present our latest work published in Science Translational Medicine. Together with Magdalena Król and her team (especially Maciej Bialasek), we've developed a groundbreaking cell therapy against glioblastoma that not only kills cancer cells but also induces anti-tumor immunity.
June 18, 2025 at 10:02 PM
We're thrilled to present our latest work published in Science Translational Medicine. Together with Magdalena Król and her team (especially Maciej Bialasek), we've developed a groundbreaking cell therapy against glioblastoma that not only kills cancer cells but also induces anti-tumor immunity.
Proud of Marc R. Borsi, our talented M.sc student in our neurodeg biomarker group @unispitalzuerich.bsky.social CSF lab & memory clinic, presenting parts of his thesis work on prognostic features in non-AD or #SNAP @ #ADPD25 .
Congrats on this nice work!
Congrats on this nice work!
April 5, 2025 at 8:25 AM
Proud of Marc R. Borsi, our talented M.sc student in our neurodeg biomarker group @unispitalzuerich.bsky.social CSF lab & memory clinic, presenting parts of his thesis work on prognostic features in non-AD or #SNAP @ #ADPD25 .
Congrats on this nice work!
Congrats on this nice work!
Great „stimulating“ talk by @sjschreiner.bsky.social on Sleep Modulation as a potential non-pharmacological treatment option in #ParkinsonDisease.
Excited to see future updates!
@unispitalzuerich.bsky.social
Excited to see future updates!
@unispitalzuerich.bsky.social
April 1, 2025 at 2:47 PM
Great „stimulating“ talk by @sjschreiner.bsky.social on Sleep Modulation as a potential non-pharmacological treatment option in #ParkinsonDisease.
Excited to see future updates!
@unispitalzuerich.bsky.social
Excited to see future updates!
@unispitalzuerich.bsky.social
🧠 Just out on medRxiv:
Our study led by Simon Schreiner, Christian Baumann and many more reveals *distinct sleep phenotypes in neurodegenerative Parkinsonism* - potential non-invasive biomarkers for α-synucleinopathy vs. tauopathy!
📝 Read the full preprint: www.medrxiv.org/content/10.1...
Our study led by Simon Schreiner, Christian Baumann and many more reveals *distinct sleep phenotypes in neurodegenerative Parkinsonism* - potential non-invasive biomarkers for α-synucleinopathy vs. tauopathy!
📝 Read the full preprint: www.medrxiv.org/content/10.1...
March 15, 2025 at 9:33 AM
🧠 Just out on medRxiv:
Our study led by Simon Schreiner, Christian Baumann and many more reveals *distinct sleep phenotypes in neurodegenerative Parkinsonism* - potential non-invasive biomarkers for α-synucleinopathy vs. tauopathy!
📝 Read the full preprint: www.medrxiv.org/content/10.1...
Our study led by Simon Schreiner, Christian Baumann and many more reveals *distinct sleep phenotypes in neurodegenerative Parkinsonism* - potential non-invasive biomarkers for α-synucleinopathy vs. tauopathy!
📝 Read the full preprint: www.medrxiv.org/content/10.1...